Companies: 10,795·Total market cap: $144.5T
Edwards Lifesciences Corporation

Edwards Lifesciences Corporation

EWNYSEHealthcare● Active
$86.37
+$0.41(+0.48%)
Market Cap$49.7B
P/E Ratio
52W High$89.14
52W Low$72.3

Edwards Lifesciences Corporation (EW) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

ew · stock forecast · 48 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 48 Wall Street analysts in the past 3 months

SellBuy

Buy

48 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
32
Hold
16
Sell
0
Strong Sell
0
Total: 48 · Buy rate: 66.7%

12-Month Price Target

High

$110

Consensus

$96.83

+12.7% upside

Low

$85.00

Median: $95 · Last Close: $85.93

The Edwards Lifesciences Corporation (EW) analyst consensus is Buy, based on ratings from 48 Wall Street analysts over the past 3 months. The average 12-month EW price target is $96.83, representing +12.7% upside from the current price of $85.93.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $97 (12.7%)

Consensus Target

$96.83

12.7% upside

High Target

$110

28.0%

Low Target

$85

-1.1%

Current Price

$85.93

as of today

Based on analyst price targets, the EW stock price prediction for the next 12 months ranges from $85 to $110. The consensus EW price forecast of $96.83 implies 12.7% upside from the current price of $85.93.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$87.481.80%

1-day model range: $87.2–$87.75. Peak: $87.75 (+1.80%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$86+0.3%
2028$86+0.6%
2029$87+0.7%
2030$87+0.8%
2031+0.9%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

64%7%29%
9Buy
1Neutral
4Sell
RSI (14)62.2Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · EW · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$86.60SELL
MA 10$86.76SELL
MA 20$84.26BUY
MA 50$82.30BUY
MA 100$82.28BUY
MA 200$81.75BUY
Current $EW · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$86.38SELL
EMA 10$86.08SELL
EMA 20$85.02BUY
EMA 50$83.46BUY
EMA 100$82.68BUY
EMA 200$81.42BUY
Current $EW · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
TD Cowen2026-06-02
Maintains
BuyBuy
Barclays2026-04-27
Maintains
OverweightOverweight
BTIG2026-04-24
Maintains
BuyBuy
Canaccord Genuity2026-04-24
Maintains
HoldHold
Baird2026-04-24
Maintains
NeutralNeutral
Evercore ISI Group2026-04-24
Maintains
OutperformOutperform
Truist Securities2026-04-24
Maintains
HoldHold
Mizuho2026-04-13
Maintains
OutperformOutperform
Evercore ISI Group2026-04-06
Maintains
OutperformOutperform
Truist Securities2026-02-11
Maintains
HoldHold

Wall Street analysts have recently issued updated ratings on Edwards Lifesciences Corporation (EW) stock. Of the recent 526 rating actions, 50 were upgrades and 35 were downgrades. 48 analysts currently cover EW.

Analyst Recommendation Trends

Buy ratings11
Hold ratings202
Sell ratings00

EW analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$6.8B

↓ 17.3% YoY

Revenue Next Year

$7.4B

↑ 9.9% YoY

EPS This Year

$3.01

EPS Next Year

$3.38

↑ 12.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast EW EPS of $3.01 for the current fiscal year, based on estimates from 16 analysts. The EW revenue forecast is $6.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The EW stock forecast is supported by two independent data sources: analyst consensus ratings from 48 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus EW price target is $96.83 (+12.7% upside), with an analyst consensus of Buy.

The EW short-term stock prediction for tomorrow is $87.48 (+1.80%). The EW stock price prediction for 2027 estimates an average of $86. The EW stock prediction for 2030 projects a range of $84–$90.

Edwards Lifesciences Corporation trades on NYSE under the ticker EW. The EW stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

EW forecast · 8 questions

According to 48 Wall Street analysts, the average 12-month EW price target is $96.83, with a high forecast of $110.00 and a low of $85.00. The median price target is shown in the chart above when available. This implies +12.7% potential upside from the current price of $85.93.

EW price targetWhat is EW price targetEW analyst price targetEW 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.